Stem Cell Theranostics Overview

  • Status
  • Out of Business
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Out of Business

Stem Cell Theranostics General Information

Description

Developer of genetically-targeted therapies designed to treat heart failure. The companies therapies offer personalized medicine through the use of patient-derived cell models, enabling patients to start treatment more quickly, resulting in a better medical outcome.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Delivery
Primary Office
  • 640 Galveston Drive
  • Redwood City, CA 94063
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Stem Cell Theranostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 01-Jun-2017 00.000 Completed Out of Business
6. Grant 01-Jan-2017 00000 00.000 Completed Startup
5. Early Stage VC (Series B1) 05-Aug-2016 00.000 00.000 000.00 Completed Startup
4. Early Stage VC (Series A) 22-Jan-2014 00.000 00.000 000.00 Completed Startup
3. Grant 0000 Completed Startup
2. Accelerator/Incubator 13-Sep-2013 Completed Startup
1. Grant 01-Jan-2012 $150K Completed Startup
To view Stem Cell Theranostics’s complete valuation and funding history, request access »

Stem Cell Theranostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-1 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Stem Cell Theranostics’s complete cap table history, request access »

Stem Cell Theranostics Executive Team (8)

Name Title Board Seat Contact Info
Joseph Wu Ph.D Co-Founder & Board Member
Divya Nag Co-Founder
Michelle Sibley Chief Financial Officer, Board Member & Secretary
Andrew Lee Ph.D Co-Founder & Chief Scientific Officer
Robert Robbins MD Co-Founder & Chairman
You’re viewing 5 of 8 executive team members. Get the full list »

Stem Cell Theranostics Board Members (4)

Name Representing Role Since
Gregory Sachs Self Deputy Chairman 000 0000
Joseph Wu Ph.D Stem Cell Theranostics Co-Founder & Board Member 000 0000
Peter Fitzgerald Ph.D Self Board Member 000 0000
Robert Robbins MD Self Co-Founder & Chairman 000 0000
To view Stem Cell Theranostics’s complete board members history, request access »

Stem Cell Theranostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Stem Cell Theranostics Subsidiaries (1)

Company Name Industry Location Founded
00000000 000000000 Biotechnology Toronto, Canada 0000
To view Stem Cell Theranostics’s complete subsidiaries history, request access »